Genspeed Biotech

Genspeed Biotech GmbH is an Austrian medical technology company that specializes in rapid diagnostic testing solutions. Founded in 2016 as a spin-off from Greiner Bio-One, the company developed the proprietary GENSPEED technology platform, which integrates microfluidics, miniaturized optoelectronics, and automation. This system allows for the simultaneous detection of up to eight parameters—including nucleic acids and proteins—from a single patient sample. The platform is designed to deliver laboratory-grade sensitivity and quantitative results at the point-of-care within minutes, providing a versatile solution for both clinical and industrial diagnostic applications.

The company serves as an OEM partner for test manufacturers looking to transition to rapid, multiplexed testing or meet evolving regulatory requirements. By offering an adaptable platform, Genspeed enables partners to develop or migrate assays for various medical and industrial use cases. Their own IVD-CE certified product portfolio includes tests for periodontal pathogens, hospital-acquired infections, and Vitamin D. Through these solutions, Genspeed aims to provide fast, actionable results that support clinical decision-making and improve diagnostic accessibility in decentralized settings.